Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-023724
Filing Date
2025-03-14
Accepted
2025-03-14 07:27:34
Documents
1
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm259169-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm259169-1_4seq1.xml 4 3722
  Complete submission text file 0001104659-25-023724.txt   5381
Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address
WEAVER GREGORY L (Reporting) CIK: 0001251779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 25737655

Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)